C WorldWide Group Holding A S Cuts Stake in Mylan N.V. (NASDAQ:MYL)

C WorldWide Group Holding A S cut its position in Mylan N.V. (NASDAQ:MYL) by 9.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 194,639 shares of the company’s stock after selling 19,152 shares during the period. C WorldWide Group Holding A S’s holdings in Mylan N.V. were worth $7,556,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently made changes to their positions in the company. Cleararc Capital Inc. increased its stake in shares of Mylan N.V. by 0.6% in the first quarter. Cleararc Capital Inc. now owns 10,394 shares of the company’s stock worth $405,000 after buying an additional 67 shares in the last quarter. Conning Inc. increased its stake in shares of Mylan N.V. by 1.3% in the first quarter. Conning Inc. now owns 10,128 shares of the company’s stock worth $395,000 after buying an additional 130 shares in the last quarter. Sei Investments Co. increased its stake in shares of Mylan N.V. by 1.0% in the first quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock worth $541,000 after buying an additional 134 shares in the last quarter. Bank of Nova Scotia increased its stake in shares of Mylan N.V. by 1.9% in the first quarter. Bank of Nova Scotia now owns 10,525 shares of the company’s stock worth $410,000 after buying an additional 196 shares in the last quarter. Finally, Wade G W & Inc. increased its stake in shares of Mylan N.V. by 3.6% in the first quarter. Wade G W & Inc. now owns 6,156 shares of the company’s stock worth $240,000 after buying an additional 213 shares in the last quarter. Institutional investors own 70.19% of the company’s stock.

Shares of Mylan N.V. (NASDAQ MYL) opened at 32.29 on Friday. The firm has a market capitalization of $17.31 billion, a PE ratio of 32.26 and a beta of 1.27. The stock has a 50 day moving average price of $37.57 and a 200 day moving average price of $39.05. Mylan N.V. has a 1-year low of $29.58 and a 1-year high of $49.42.

Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The firm had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the previous year, the company posted $1.16 earnings per share. The firm’s revenue was up 15.7% on a year-over-year basis. Equities research analysts anticipate that Mylan N.V. will post $4.68 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.com-unik.info/2017/08/11/c-worldwide-group-holding-a-s-cuts-stake-in-mylan-n-v-nasdaqmyl.html.

Several research firms recently commented on MYL. Royal Bank Of Canada set a $41.00 target price on Mylan N.V. and gave the stock a “hold” rating in a research report on Saturday, May 13th. Cantor Fitzgerald set a $34.00 target price on Mylan N.V. and gave the stock a “hold” rating in a research report on Wednesday. Cowen and Company restated a “hold” rating and set a $30.00 target price (down previously from $43.00) on shares of Mylan N.V. in a research report on Wednesday. UBS AG restated a “buy” rating and set a $46.00 target price (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday. Finally, BMO Capital Markets restated an “outperform” rating and set a $45.00 target price (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday. Two analysts have rated the stock with a sell rating, eleven have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. Mylan N.V. has an average rating of “Buy” and an average target price of $47.83.

In other news, insider Anthony Mauro sold 10,000 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the completion of the transaction, the insider now directly owns 140,653 shares in the company, valued at approximately $5,626,120. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Rajiv Malik sold 25,000 shares of the stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the transaction, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by corporate insiders.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

What are top analysts saying about Mylan N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mylan N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit